TH132267B - Pyrazole derivatives - Google Patents
Pyrazole derivativesInfo
- Publication number
- TH132267B TH132267B TH1301003290A TH1301003290A TH132267B TH 132267 B TH132267 B TH 132267B TH 1301003290 A TH1301003290 A TH 1301003290A TH 1301003290 A TH1301003290 A TH 1301003290A TH 132267 B TH132267 B TH 132267B
- Authority
- TH
- Thailand
- Prior art keywords
- disorder
- disease
- diseases
- formula
- hypertension
- Prior art date
Links
- 150000003217 pyrazoles Chemical class 0.000 title claims 2
- 150000003839 salts Chemical class 0.000 claims abstract 2
- 239000011780 sodium chloride Substances 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims abstract 2
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 2
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000004429 atoms Chemical group 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract 5
- 206010020772 Hypertension Diseases 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 206010040984 Sleep disease Diseases 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 206010000117 Abnormal behaviour Diseases 0.000 abstract 1
- 206010001897 Alzheimer's disease Diseases 0.000 abstract 1
- 206010003816 Autoimmune disease Diseases 0.000 abstract 1
- 206010013663 Drug dependence Diseases 0.000 abstract 1
- 206010033666 Panic disease Diseases 0.000 abstract 1
- 206010061536 Parkinson's disease Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000009596 autoimmune hypersensitivity disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000020595 eating behavior Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002124 endocrine Effects 0.000 abstract 1
- 230000000762 glandular Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
Abstract
สารประกอบที่เเสดงด้วยสูตร(IA)หรือเกลือของสารดังกล่าวซึ่งเป็นที่ยอมรับทางเภสัชกรรม ซึ่งมีประโยชน์สำหรับการรักษาหรือการป้องกันโรค เช่น ความผิดปกติของการนอนหลับ(sleep disorder)ภาวะซึมเศร้า(dephizession)กลุ่มอาการวิตกกังวล(anxicty disorder)โรคตื่นตระหนก (panic disorder)โรคจิตเภท(schizophernia)การติดยา(drug dependence)โรคอัลไซเมอร์ (Alzheimer disease)โรคพาร์คินสัน(parkinson disease)ฮันทิงทันส์คอเรีย(Huntington's chrea),ความผิดปกติด้านพฤติกรรมการกินอาหาร(enting disorder),อาการเจ็บปวด(psin), โรคทางเดินอาหาร(gastorintestianl discas)โรคลมชัก(epilcpsy)การอักเสบ(inflammation) โรคที่เกี่ยวข้องกับระบบภูมิคุ้ม กัน(immune-related diseases)โรคเกี่ยวข้องกับระบบต่อมไรท่อ (endocrine-related discases)เเละความดันเลือดสูง(hypertension)เเละการเเสดงออกฤทธิ์สารขึ้นอยู่ กับฤทธิ์ต้านโอเร็กซิน(OX)รีเซพเทอร์ (สูตรเคมี) Compounds shown with the formula (IA) or their salts, which are pharmacologically acceptable. Which is useful for the treatment or prevention of diseases such as sleep disorders (sleep disorder), dephizession, anxicty disorder) panic disorder, schizophernia, drug addiction dependence) Alzheimer's disease, Parkinson's disease disease) Huntington's chrea), eating behavior disorder (enting disorder), painful symptoms (psin), gastorintestianl discas), epilcpsy, inflammation (inflammation), an autoimmune disease Immune-related diseases) Diseases are related to the glandular system. (endocrine-related discases) and hypertension (hypertension) and their active ingredient dependence. With anti-Orexin (OX) receptor activity (chemical formula)
Claims (1)
Publications (2)
Publication Number | Publication Date |
---|---|
TH132267B true TH132267B (en) | 2014-04-01 |
TH132267A TH132267A (en) | 2014-04-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12014502751A1 (en) | Branched chain alkyl heteroaromatic ring derivative | |
AU2012258977A8 (en) | Inhibitors of LRRK2 kinase activity | |
PH12014502750A1 (en) | Heteroaromatic methyl cyclic amine derivative | |
EA201790228A1 (en) | COMPOSITIONS AND METHODS OF OBTAINING PYRIMIDINE AND PYRIDINE COMPOUNDS WITH BTK INHIBITING ACTIVITY | |
EA201391029A1 (en) | OXAZIN DERIVATIVES AND THEIR APPLICATION IN THE TREATMENT OF NEUROLOGICAL DISORDERS | |
DK2150530T3 (en) | Substituted sulfonamide derivatives | |
MX2014000536A (en) | 4 - piperidinyl compounds for use as tankyrase inhibitors. | |
NO20085257L (en) | Purinone derivatives as HM74a agonists | |
WO2012048129A3 (en) | Inhibitors of polo-like kinase | |
EA201400067A1 (en) | NEW THERAPEUTIC COMPOSITION CONTAINING APOMORPHIN AS AN ACTIVE INGREDIENT | |
MX2013006715A (en) | Pyrazole derivative. | |
WO2011107608A8 (en) | Heterocyclic amides as rock inhibitors | |
NZ605431A (en) | D2 antagonists, methods of synthesis and methods of use | |
MX2011010732A (en) | Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease. | |
EA201490630A1 (en) | 6-SUBSTITUTED 3- (QUINOLIN-6-ILTIO) [1,2,4] TRIAZOLO [4,3-A] Pyridine as inhibitors of C-MET THYROZINKINASE | |
EA201490754A1 (en) | DERIVATIVES OF CARBAMATE / URINE, CONTAINING PIPERIDINE AND PIPERAZINE RINGS AS RECEPTOR INHIBITORS | |
BR112013026361A2 (en) | glycoside derivatives and uses thereof | |
FR2981933B1 (en) | OXOAZETIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS | |
BR112012026509A2 (en) | "new benzamide derivatives" | |
BR112015029724A2 (en) | ethinyl derivatives as metabotropic glutamate receptor antagonists | |
TH132267B (en) | Pyrazole derivatives | |
EA201590722A1 (en) | DERIVATIVES OF ETHYNES AS MODELS OF ACTIVITY OF METABOTROPIC GLUTAMATE RECEPTOR OF SUBTLE 5 | |
TH132267A (en) | Pyrazole derivatives | |
TR200802061A2 (en) | Pharmaceutical formulation containing highly active ingredient. | |
WO2010134846A8 (en) | Substituted 8-sulfonyl-2,3,4,5-tetrahydro-1h-gamma-carbolines, ligands and pharmaceutical composition; method for the production and use of same |